Hospital
Tooele Hospital Corporation
Tooele Hospital Corporation was paid $11.66M by Medicaid between Jan 2018 and Nov 2024, across 126 billing codes. Its largest line is 8888888, Internal/system code - not a standard HCPCS code — 76% of everything it billed.
33Billing provider infoTOOELE HOSPITAL CORPORATION
TOOELE, UT 84074
TOOELE, UT 84074
33aNPI1124090659assigned 02/07/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.66M
24GClaims201,445
24DCodes billed126
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Utah
Rank by total paid#9 of 26
Median peer was paid$6.14M
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official COOPER, RANDY controls 18+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,624 | $1.48M | |
| 2019 | 33,160 | $1.85M | |
| 2020 | 38,866 | $2.25M | |
| 2021 | 49,034 | $2.91M | |
| 2022 | 44,684 | $2.96M | |
| 2023 | 3,040 | $172K | |
| 2024incomplete | 1,037 | $35K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 8888888 | Internal/system code - not a standard HCPCS code | 76% | 41,528 | 10,075 | $8.85M |
| 80053 | Comprehensive metabolic panel | 3.0% | 12,021 | 9,543 | $346K |
| 36415 | Collection of venous blood by venipuncture | 2.6% | 4,472 | 3,493 | $305K |
| 83605 | 2.4% | 3,776 | 2,921 | $284K | |
| 84484 | 2.4% | 3,543 | 2,497 | $280K | |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.0% | 6,466 | 5,798 | $234K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.7% | 10,145 | 8,616 | $200K |
| 80306 | 1.1% | 2,271 | 1,901 | $131K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.0% | 1,259 | 1,133 | $119K |
| 86850 | <1% | 904 | 814 | $85K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,664 | 1,346 | $62K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,338 | 2,064 | $47K |
114 more codes
| 0225U | <1% | 494 | $38K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,595 | $36K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,291 | $34K |
| 87400 | <1% | 696 | $34K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 596 | $34K |
| 86901 | <1% | 1,094 | $33K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,283 | $32K |
| 99285 | Emergency room visit (most serious) | <1% | 4,685 | $31K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 738 | $31K |
| 81025 | <1% | 2,155 | $28K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,248 | $27K |
| 81001 | <1% | 8,072 | $26K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,484 | $24K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,779 | $24K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 168 | $19K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,694 | $17K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 472 | $16K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,845 | $15K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,341 | $14K |
| 87430 | <1% | 369 | $13K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,990 | $12K |
| 82962 | <1% | 1,794 | $11K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 633 | $10K |
| 87186 | <1% | 888 | $10K | |
| 85610 | <1% | 2,095 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,809 | $9K |
| 76830 | Ultrasound, transvaginal | <1% | 180 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,931 | $8K |
| 31720 | <1% | 78 | $7K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,786 | $6K |
| 87807 | <1% | 249 | $6K | |
| 83690 | <1% | 4,203 | $6K | |
| 84703 | <1% | 1,429 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 33 | $5K |
| 73610 | <1% | 59 | $5K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 506 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 141 | $4K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 55 | $4K |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 230 | $4K |
| 73630 | <1% | 70 | $4K | |
| 86900 | <1% | 922 | $4K | |
| 83880 | <1% | 503 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 129 | $3K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,582 | $3K |
| 59025 | Fetal non-stress test | <1% | 60 | $3K |
| 84702 | <1% | 296 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,601 | $2K |
| 93971 | <1% | 26 | $2K | |
| 85379 | <1% | 797 | $2K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 301 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,704 | $2K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 121 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 160 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 469 | $2K |
| 74018 | <1% | 44 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,921 | $1K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 44 | $1K |
| 82805 | <1% | 53 | $1K | |
| G0378 | Hospital observation service, per hour | <1% | 869 | $1K |
| 80320 | <1% | 1,265 | $1K | |
| 73130 | <1% | 17 | $842.27 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 639 | $781.05 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 30 | $752.11 |
| 87081 | <1% | 160 | $733.82 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 125 | $685.81 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 680 | $654.63 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 293 | $644.17 |
| 82550 | <1% | 25 | $603.64 | |
| 97161 | <1% | 277 | $545.71 | |
| 87999 | <1% | 13 | $515.64 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 489 | $359.68 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 131 | $337.96 |
| 72100 | <1% | 12 | $323.75 | |
| 80299 | <1% | 1,678 | $224.69 | |
| 80061 | Lipid panel | <1% | 60 | $186.65 |
| 84439 | <1% | 47 | $162.58 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 400 | $138.88 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,465 | $137.14 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 224 | $102.92 |
| 87088 | <1% | 516 | $96.24 | |
| 86140 | <1% | 91 | $81.78 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 814 | $70.27 |
| 82950 | <1% | 178 | $35.97 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 69 | $26.47 |
| 87040 | <1% | 690 | $19.57 | |
| 83735 | <1% | 379 | $19.46 | |
| 85027 | <1% | 25 | $5.71 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 654 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 455 | $0.00 |
| 96376 | 0% | 1,069 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 224 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 1,017 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 1,064 | $0.00 |
| 80329 | 0% | 205 | $0.00 | |
| 94761 | 0% | 1,380 | $0.00 | |
| J1741 | Injection, ibuprofen, 100 mg | 0% | 249 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 80 | $0.00 |
| 80050 | General health panel | 0% | 14 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 80 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 19 | $0.00 |
| 85652 | 0% | 31 | $0.00 | |
| 82150 | 0% | 14 | $0.00 | |
| 70496 | 0% | 14 | $0.00 | |
| 85730 | 0% | 41 | $0.00 | |
| 70498 | 0% | 14 | $0.00 | |
| 87210 | 0% | 15 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 606 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 18 | $0.00 |
| 84145 | 0% | 13 | $0.00 | |
| 76937 | 0% | 15 | $0.00 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 61 | $0.00 |
| 87631 | 0% | 17 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 17 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOOPER, RANDY (SVP FINANCE OP/AUTHORIZED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Jackson Hospital Corporation | Jackson, KY | $34.90M |
| Deming Hospital Corporation | Deming, NM | $34.61M |
| Hospital of Louisa, INC. | Louisa, KY | $27.77M |
| Hospital of Barstow INC | Barstow, CA | $16.88M |
| Paintsville Hospital Company, LLC | Paintsville, KY | $15.46M |
| San Miguel Hospital Corporation | Las Vegas, NM | $13.21M |
| Forrest City Arkansas Hospital Company LLC | Forrest City, AR | $7.42M |
| MMC of Nevada LLC | Mesquite, NV | $2.60M |
| Fort Payne Hospital Corporation | Fort Payne, AL | $2.60M |
| Williamston Hospital Corporation | Williamston, NC | $2.31M |
| Waukegan Illinois Hospital Company LLC | Waukegan, IL | $2.30M |
| Southwest Kidney Institute Vascular Center LLC | Tempe, AZ | $850K |
| Evanston Hospital Corporation | Evanston, WY | $378K |
| Marion Hospital Corporation | Marion, IL | $220K |
| Anna Hospital Corporation | Anna, IL | $217K |
| National Healthcare of MT Vernon INC | Mount Vernon, IL | $158K |
| Red Bud Illinois Hospital Company LLC | Red Bud, IL | $36K |
| Tooele Hospital Corporation | Tooele, UT | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.